The most disruptive and sustainable construction meets at Tomorrow.Building World Congress
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
BARCELONA, Spain, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Showcasing the most groundbreaking projects to promote innovative and sustainable construction. This is the main goal of Tomorrow.Building World Congress (TBWC), an event organized by Fira de Barcelona featuring leading companies in the transformation of the sector, as well as startups with innovative initiatives. In addition, TBWC also aims to promote debate on the future of the sector with a hundred experts who will address its challenges in decarbonisation, digitalisation and sustainable urban development.
From November 7 – 9, the event will gather some 50 companies with a disruptive spirit and a firm commitment to sustainability willing to transform the construction sector.
These include major international companies such as Samsung C&T Corporation and Siemens, leaders in the development of smart cities; Samoo Architects & Engineers, a Korean architecture firm with sustainable and efficient designs worldwide, as well as CBRE, Drees&Sommer, Johnson Controls, Roshn Group and SPIE. There will also be room for companies with innovative projects such as Bioo, which has developed an initiative to produce electricity through plant photosynthesis.
The event also aims to promote knowledge and debate in the industry on issues such as design technology, green districts, decarbonisation and PropTech, as well as issues of today's and tomorrow's cities, such as access to affordable and sustainable housing, urban readiness to welcome refugees and the acceleration of the energy transition.
The congress programme will feature a hundred experts including, among others, Nate Blecharczyk, Co-founder and Director of Strategy of Airbnb; Lebanese architect and specialist in Artificial Intelligence, Chantal Matar; Peter Körte, Director of Technology at Siemens; Peggy Deamer, Professor Emeritus at the Yale School of Architecture and Founder of The Architecture Lobby; Natalia Oliver, architect and specialist in BIM; and Piero Pelizzaro, Director of the National Hub for the Regeneration of Public buildings and expert in climate change policies.
In addition, FC Barcelona will present the latest details of the construction project of the new Spotify Camp Nou and its initiative for the renovation of its urban environment, Espai Barça.
Tomorrow.Building is held alongside Smart City Expo World Congress, Tomorrow.Mobility, Tomorrow.Blue Economy and PUZZLE X. Together the events will gather more than 25,000 attendees, 1,000 exhibitors, and representatives from more than 800 cities and 140 countries.
For media requests please contact:
Salvador Bilurbina
email: sbilurbina@firabarcelona.com
phone: +34628162674
A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/dd5da650-0297-4005-b058-177cebdc1970
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Karolinska Developments portföljbolag Umecrine Cognition presenterar positiv effekt med golexanolon i en preklinisk modell av kolestas28.11.2023 12:44:51 CET | Pressemelding
STOCKHOLM, SVERIGE 28 november 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget Umecrine Cognition har presenterat positiva resultat från en studie med bolagets läkemedelskandidat golexanolone i en preklinisk modell av PBC-relaterad symtomologi och neuroinflammation. Resultaten indikerar en normaliserande effekt på kognitiva symtom såsom trötthet, motoriska störningar, neuroinflammation och neurala signaler. Resultaten publiceras i novemberutgåvan av den internationellt välrenommerade tidskriften Liver International. Resultaten från den prekliniska studien, som utfördes i en validerad och välkänd sjukdomsmodell av kolestas, visar att golexanolon förbättrar symtom som vanligtvis ses vid PBC. Studien visar en tydlig minskning av central trötthet, signifikanta förbättringar av korttidsminnet och normaliserande motoriska funktioner efter en 4-5 veckors lång behandling med golexanolon. ”Trötthet är högst prioriterat för symtomlindring för PBC-patienter e
Karolinska Development’s portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis28.11.2023 12:44:51 CET | Press release
STOCKHOLM, SWEDEN – November 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented positive results from a study of the company’s drug candidate golexanolone in a preclinical model of PBC-like symptomology and neuroinflammation. The results indicate a normalizing effect on cognitive symptoms, such as fatigue, motor impairments, neuroinflammation, and neural signaling. The results are published in the November issue of the internationally renowned journal Liver International. The results from the preclinical study, which was performed in a validated and well-known disease model of cholestasis, show that golexanolone improves symptoms generally seen in PBC. The study shows a clear reduction in central fatigue, marked improvements in short-term memory, and normalized motoric functions following a 4–5-week treatment regimen with golexanolone. “Fatigue is the highest priority of symptom relief for PBC patient
Vardagen fångad i blixtbelysning28.11.2023 12:19:36 CET | Pressemelding
Uppsala, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Lars Tunbjörk 2 dec - 28 jan 2024 Bror Hjorths Hus, Uppsala Lars Tunbjörks fotografier visas i Bror Hjorths Hus Årets sista utställning i Bror Hjorths Hus visar verk ut tre serier av den svenska fotografen Lars Tunbjörk (1956–2015). Den invigs lördag 2 december och pågår till 28 januari 2024. Pressvisning: lämpligast torsdag 30 november kl 10-14 (se mer nedan) Lars Tunbjörk skapade en helt egen fotografisk stil. Den genomsyrade alla hans bilder, oavsett om det rörde sig om foton av hemstaden Borås, det svenska landskapet och dess olika årstider, kontorsmiljöer eller modeller i Paris. Med en säregen blick, tålamod och passion dokumenterade han vardagen i skarp blixtbelysning. Lars Tunbjörks började som pressfotograf och 1982 fick han utmärkelsen Årets fotograf. Det stora genombrottet kom drygt tio år senare med fotoboken Landet utom sig – en både roande och oroande dokumentation av svensk vardag runt decennieskiftet 1990. Ett urval av dessa fot
Registration of share capital increase in IDEX Biometrics 28 Nov 202328.11.2023 11:45:00 CET | Press release
Reference is made to the notice on 15 November 2023 regarding private placement of 78,651,685 shares at NOK 0.445 per share. The capital increase has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 209,493,156.- divided into 1,396,621,040 shares, each with a nominal value of NOK 0.15. For further information contact: Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: +47 918 00186 About IDEX Biometrics IDEX Biometrics (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all. We help people make payments, prove their identity, gain access to information or unlock devices with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity. For more information, vi
DSV, 1073 - SHARE BUYBACK IN DSV A/S28.11.2023 10:43:00 CET | Press release
Company Announcement No. 1073 On 24 October 2023, we initiated a share buyback programme, as described in Company Announcement No. 1066. According to the programme, the company will in the period from 24 October 2023 until 31 January 2024 purchase own shares up to a maximum value of DKK 2,500 million, and no more than 4,000,000 shares, corresponding to 1.83% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. The following transactions have been recorded under the programme: Trading dayTrading platformNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-19815,2971,055.73860,736,39420:20 November 2023AQEU1,7251,089.31CEUX5,7061,089.9